Yaribeygi Habib, Atkin Stephen L, Sahebkar Amirhossein
Chronic Kidney Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Weill Cornell Medicine Qatar, Doha, Qatar.
J Cell Biochem. 2019 Jul;120(7):10909-10913. doi: 10.1002/jcb.28467. Epub 2019 Feb 18.
Dipeptidyl peptidase-4 (DPP-4) inhibitors are antidiabetes agents that decrease blood glucose by preventing the degradation of endogenous glucagon-like peptide-1. The first DPP-4 was sitagliptin followed by several other agents in the class introduced to manage diabetes. Recent studies have suggested that naturally occurring compounds can exert an antidiabetes effect through DPP-4 inhibition. Such compounds may have a place in the treatment of diabetes within the diet; however, while DPP-4 inhibition alone is not associated with hypoglycemia, in combinations with other medication hypoglycemia can result, therefore, it is critical to know what herbal or food-based compounds may have these activities in the management of diabetes patients. In this review, we have outlined the compounds that have DPP-4 inhibition that may have utility in the treatment of diabetes.
二肽基肽酶-4(DPP-4)抑制剂是一类抗糖尿病药物,通过阻止内源性胰高血糖素样肽-1的降解来降低血糖。首个DPP-4抑制剂是西他列汀,随后该类又有其他几种药物被用于治疗糖尿病。最近的研究表明,天然存在的化合物可通过抑制DPP-4发挥抗糖尿病作用。这类化合物在糖尿病饮食治疗中可能占有一席之地;然而,虽然单独抑制DPP-4不会导致低血糖,但与其他药物联用时可能会引发低血糖,因此,了解哪些草药或食物类化合物在糖尿病患者管理中可能具有这些作用至关重要。在本综述中,我们概述了具有DPP-4抑制作用、可能对糖尿病治疗有用的化合物。